Treatment of overactive bladder: what is on the horizon?
Authors:
- 3 July 2012
- journal article
- review article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 24 (1) , 5-13
Abstract
There is still a need to develop additional effective and well-tolerated therapies for the treatment of overactive bladder (OAB). The purpose of this review is to discuss alternative therapies for idiopathic OAB that employ a unique mechanism of action or offer a novel application of an existing therapy. We performed a comprehensive literature review to identify alternative therapies and potential future treatments for idiopathic OAB. The use of botulinumtoxin for idiopathic OAB is on the rise and FDA approval will likely be granted in the future. New innovations in neuromodulation hold the promise of less invasive and more patient-controlled therapies. A number of novel medications, such as β-adrenoreceptor agonists, or medications with alternative indications, such as phosphodiesterase inhibitors, have been identified as potential therapies for OAB. In addition, novel drug delivery systems, such as vaginal inserts, are also in development and may provide an attractive mechanism to deliver medications with proven efficacy. While conservative measures such as behavioral modification and pelvic floor exercises remain first-line therapy for OAB, anti-muscarinics are the mainstay of medical treatment. For patients with idiopathic OAB refractory to traditional first-line therapies, a number of promising new treatments are on the horizon.Keywords
This publication has 50 references indexed in Scilit:
- Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinicsNeurourology and Urodynamics, 2011
- 1959 MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN STUDYJournal of Urology, 2011
- Expression and distribution of transient receptor potential (TRP) channels in bladder epitheliumAmerican Journal of Physiology-Renal Physiology, 2011
- Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured ratsGene Therapy, 2009
- Dorsal genital nerve stimulation for the treatment of overactive bladder symptomsNeurourology and Urodynamics, 2007
- A novel surgical technique for implanting a new electrostimulation system for treating female overactive bladder: a preliminary reportBJU International, 2005
- Mechanisms of neurokinin A‐ and substance P‐induced contractions in rat detrusor smooth muscle in vitroBJU International, 2004
- Urodynamic Effect of Acute Transcutaneous Posterior Tibial Nerve Stimulation in Overactive BladderJournal of Urology, 2003
- EVIDENCE OF A PERIPHERAL ROLE OF NEUROKININS IN DETRUSOR HYPERREFLEXIA: A FURTHER STUDY OF SELECTIVE TACHYKININ ANTAGONISTS IN CHRONIC SPINAL INJURED RATSJournal of Urology, 2001
- Increase in Presumptive Sensory Nerves of the Urinary Bladder in Idiopathic Detrusor InstabilityBritish Journal of Urology, 1992